BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Adamas Pharmaceuticals 

1900 Powell Street
Suite 1050
Emeryville  California  94608  U.S.A.
Phone: 510-450-3500 Fax: 510-428-0519


SEARCH JOBS




Industry
Pharmaceutical

Segment
Pharmaceuticals





 Company News
Adamas Pharmaceuticals (ADMS) Issued Six Additional U.S. Patents 12/4/2014 4:31:36 PM
Adamas Pharmaceuticals (ADMS) To Present At Piper Jaffray Healthcare Conference 11/19/2014 12:45:19 PM
Adamas Pharmaceuticals (ADMS) To Present At 2014 Credit Suisse Healthcare Conference 11/6/2014 8:21:18 AM
Adamas Pharmaceuticals (ADMS) Reports Third Quarter 2014 Financial Results 11/5/2014 7:46:03 AM
Adamas Pharmaceuticals (ADMS) Expands Its Phase 3 Program With ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Patients With Parkinson's Disease 10/29/2014 7:19:28 AM
Adamas Pharmaceuticals (ADMS) Reports Second Quarter 2014 Financial Results 8/8/2014 10:50:57 AM
United States Patent Issued To Adamas Pharmaceuticals (ADMS) 8/5/2014 3:49:07 PM
Adamas Pharmaceuticals (ADMS) To Present At JMP Securities Healthcare Conference 2014 6/17/2014 12:25:21 PM
Adamas Pharmaceuticals (ADMS) Announces Rater Training Data On ADS-5102 For Parkinson's Disease Patients With Levodopa-Induced Dyskinesia 6/10/2014 10:08:44 AM
Adamas Pharmaceuticals (ADMS) Initiates Phase 3 Trial For ADS-5102 In Parkinson's Disease Patients With Levodopa-Induced Dyskinesia 6/10/2014 9:03:15 AM
1234